0000899243-18-009785.txt : 20180409
0000899243-18-009785.hdr.sgml : 20180409
20180409182845
ACCESSION NUMBER: 0000899243-18-009785
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180409
FILED AS OF DATE: 20180409
DATE AS OF CHANGE: 20180409
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SPICKSCHEN THORLEF
CENTRAL INDEX KEY: 0001268374
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35347
FILM NUMBER: 18746548
MAIL ADDRESS:
STREET 1: TRAUBENWEG 25
CITY: 64342 SEEHEIN-JUGENHEIM
STATE: 2M
ZIP: 00000
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Clovis Oncology, Inc.
CENTRAL INDEX KEY: 0001466301
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 900475355
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5500 FLATIRON PARKWAY
STREET 2: SUITE 100
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: (303) 625-5000
MAIL ADDRESS:
STREET 1: 5500 FLATIRON PARKWAY
STREET 2: SUITE 100
CITY: BOULDER
STATE: CO
ZIP: 80301
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-04-09
0
0001466301
Clovis Oncology, Inc.
CLVS
0001268374
SPICKSCHEN THORLEF
C/O CLOVIS ONCOLOGY, INC.
5500 FLATIRON PARKWAY, SUITE 100
BOULDER
CO
80301
1
0
0
0
Common Stock
2018-04-09
4
S
0
4500
60.02
D
7618
D
This transaction was executed in multiple trades at prices ranging from $60.00 to $60.16. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2017.
/s/ Thorlef Spickschen
2018-04-09